Fathom Holdings (NASDAQ: FTHM) faces Nasdaq bid-price warning and delisting risk
Rhea-AI Filing Summary
Fathom Holdings Inc. has received a notice from Nasdaq that its common stock no longer meets the Nasdaq Capital Market’s minimum $1.00 per share bid price requirement under Nasdaq Listing Rule 5550(a)(2). The bid price has closed below this level for the last 30 consecutive business days.
The company has 180 calendar days, until October 7, 2026, to regain compliance. If the stock closes at or above $1.00 for at least ten consecutive business days during this period, Nasdaq will confirm compliance. Fathom may receive an additional 180-day period if it meets other listing standards and commits to curing the deficiency, potentially via a reverse stock split.
If compliance is not regained, Nasdaq can move to delist the stock, which Fathom could appeal. The notice does not immediately affect trading, and the stock continues to trade on the Nasdaq Capital Market under the symbol “FTHM” while the company evaluates its options.
Positive
- None.
Negative
- Nasdaq minimum bid-price deficiency: Fathom’s stock has closed below the $1.00 bid-price requirement for 30 consecutive business days, triggering a formal non-compliance notice and starting a 180-day cure period.
- Delisting risk if compliance is not restored: Failure to regain compliance by October 7, 2026 (and any additional period) could lead to Nasdaq delisting the common stock, potentially impacting liquidity and visibility.
Insights
Nasdaq bid-price deficiency creates delisting risk if FTHM cannot lift its share price.
Fathom Holdings’ stock has traded below $1.00 for 30 consecutive business days, triggering a Nasdaq notice under Listing Rule 5550(a)(2). The company now faces a formal 180-day cure period ending on October 7, 2026 to restore compliance.
Compliance requires the share price to close at or above $1.00 for at least ten consecutive business days. If other Nasdaq Capital Market standards are met, Fathom might access a second 180-day window, likely tied to actions such as a reverse stock split, which the filing explicitly mentions as an option.
If Fathom does not regain compliance within the allowed timeframe, Nasdaq can initiate delisting proceedings, though the company could appeal to a hearings panel. The filing notes that trading continues under ticker FTHM for now, while management evaluates potential responses to the deficiency.